US 9248136
Transdermal hormone replacement therapies
granted A61KA61K31/565A61K31/57
Quick answer
US patent 9248136 (Transdermal hormone replacement therapies) held by Compass Therapeutics LLC expires Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Compass Therapeutics LLC
- Grant date
- Tue Feb 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/565, A61K31/57, A61K47/10, A61K47/14